DecImmune Therapeutics
A biotechnology company developing peptides and antibodies for inflammation and autoimmunity
2
Funding Rounds
$5.5m
Money raised
Overview
A biotechnology company developing peptides and antibodies for inflammation and autoimmunity
- Website:
- Business model: B2B
| Name | Phone | Social networks | |
|---|---|---|---|
| Mi***** Ca***** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company DecImmune Therapeutics has raised a total of $5.45m in funding over 2 rounds.
Key Insights:
- DecImmune Therapeutics funding round, February 2013: $2.25m
- DecImmune Therapeutics funding round, September 2010: $3.2m
DecImmune Therapeutics funding round, February 2013
$2.25m
DecImmune Therapeutics funding round, September 2010
$3.2m
Industries
DecImmune Therapeutics is active in the following industries: